John Ridden, CEO of Blueberry Therapeutics, recently presented at the UK-China Life Science Event run by the DIT (Department for International Trade). The event was hosted by Lancaster University and is an opportunity for Life Science companies in the Northern Powerhouse to network and pitch to Chinese companies and investors.
